UniProt ID | ADRM1_HUMAN | |
---|---|---|
UniProt AC | Q16186 | |
Protein Name | Proteasomal ubiquitin receptor ADRM1 | |
Gene Name | ADRM1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 407 | |
Subcellular Localization | Cytoplasm . Nucleus . | |
Protein Description | Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. Within the complex, functions as a proteasomal ubiquitin receptor. Engages and activates 19S-associated deubiquitinases UCHL5 and PSMD14 during protein degradation. UCHL5 reversibly associate with the 19S regulatory particle whereas PSMD14 is an intrinsic subunit of the proteasome lid subcomplex.. | |
Protein Sequence | MTTSGALFPSLVPGSRGASNKYLVEFRAGKMSLKGTTVTPDKRKGLVYIQQTDDSLIHFCWKDRTSGNVEDDLIIFPDDCEFKRVPQCPSGRVYVLKFKAGSKRLFFWMQEPKTDQDEEHCRKVNEYLNNPPMPGALGASGSSGHELSALGGEGGLQSLLGNMSHSQLMQLIGPAGLGGLGGLGALTGPGLASLLGSSGPPGSSSSSSSRSQSAAVTPSSTTSSTRATPAPSAPAAASATSPSPAPSSGNGASTAASPTQPIQLSDLQSILATMNVPAGPAGGQQVDLASVLTPEIMAPILANADVQERLLPYLPSGESLPQTADEIQNTLTSPQFQQALGMFSAALASGQLGPLMCQFGLPAEAVEAANKGDVEAFAKAMQNNAKPEQKEGDTKDKKDEEEDMSLD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTTSGALFP ------CCCCCCCCC | 29.66 | 29255136 | |
2 | Acetylation | ------MTTSGALFP ------CCCCCCCCC | 29.66 | 20068231 | |
3 | Phosphorylation | -----MTTSGALFPS -----CCCCCCCCCC | 24.70 | 24732914 | |
4 | Phosphorylation | ----MTTSGALFPSL ----CCCCCCCCCCC | 16.95 | 24732914 | |
10 | Phosphorylation | TSGALFPSLVPGSRG CCCCCCCCCCCCCCC | 34.36 | 24732914 | |
15 | Phosphorylation | FPSLVPGSRGASNKY CCCCCCCCCCCCCCE | 22.82 | 29255136 | |
19 | Phosphorylation | VPGSRGASNKYLVEF CCCCCCCCCCEEEEE | 36.36 | 26074081 | |
21 | Acetylation | GSRGASNKYLVEFRA CCCCCCCCEEEEEEC | 37.15 | 19608861 | |
21 | Ubiquitination | GSRGASNKYLVEFRA CCCCCCCCEEEEEEC | 37.15 | 21890473 | |
21 | 2-Hydroxyisobutyrylation | GSRGASNKYLVEFRA CCCCCCCCEEEEEEC | 37.15 | - | |
22 | Phosphorylation | SRGASNKYLVEFRAG CCCCCCCEEEEEECC | 21.89 | 46159931 | |
27 | Methylation | NKYLVEFRAGKMSLK CCEEEEEECCCCEEE | 28.99 | - | |
32 | Phosphorylation | EFRAGKMSLKGTTVT EEECCCCEEECEEEC | 30.34 | 8656633 | |
34 | Ubiquitination | RAGKMSLKGTTVTPD ECCCCEEECEEECCC | 47.07 | 21890473 | |
34 | Methylation | RAGKMSLKGTTVTPD ECCCCEEECEEECCC | 47.07 | - | |
36 | Phosphorylation | GKMSLKGTTVTPDKR CCCEEECEEECCCCC | 19.26 | 29449344 | |
37 | Phosphorylation | KMSLKGTTVTPDKRK CCEEECEEECCCCCC | 30.93 | 25159151 | |
39 | Phosphorylation | SLKGTTVTPDKRKGL EEECEEECCCCCCCE | 24.55 | 21815630 | |
42 | Methylation | GTTVTPDKRKGLVYI CEEECCCCCCCEEEE | 58.16 | - | |
42 | Ubiquitination | GTTVTPDKRKGLVYI CEEECCCCCCCEEEE | 58.16 | 21906983 | |
42 | Acetylation | GTTVTPDKRKGLVYI CEEECCCCCCCEEEE | 58.16 | 25953088 | |
42 | 2-Hydroxyisobutyrylation | GTTVTPDKRKGLVYI CEEECCCCCCCEEEE | 58.16 | - | |
62 | Ubiquitination | SLIHFCWKDRTSGNV CEEEEEECCCCCCCC | 38.21 | 21906983 | |
80 | Glutathionylation | LIIFPDDCEFKRVPQ EEEECCCCCCCCCCC | 9.62 | 22555962 | |
83 | Acetylation | FPDDCEFKRVPQCPS ECCCCCCCCCCCCCC | 30.14 | 26051181 | |
83 | Ubiquitination | FPDDCEFKRVPQCPS ECCCCCCCCCCCCCC | 30.14 | 21906983 | |
97 | Acetylation | SGRVYVLKFKAGSKR CCCEEEEEEEECCEE | 34.47 | 26051181 | |
97 | Ubiquitination | SGRVYVLKFKAGSKR CCCEEEEEEEECCEE | 34.47 | 21906983 | |
113 | Ubiquitination | FFWMQEPKTDQDEEH EEEECCCCCCCCHHH | 65.07 | - | |
127 | Phosphorylation | HCRKVNEYLNNPPMP HHHHHHHHHCCCCCC | 14.99 | 24275569 | |
140 | Phosphorylation | MPGALGASGSSGHEL CCCCCCCCCCCCCHH | 37.09 | 26074081 | |
142 | Phosphorylation | GALGASGSSGHELSA CCCCCCCCCCCHHHH | 30.56 | 26074081 | |
143 | Phosphorylation | ALGASGSSGHELSAL CCCCCCCCCCHHHHC | 47.93 | 26074081 | |
211 | O-linked_Glycosylation | SSSSSSRSQSAAVTP CCCCCCCCCCCCCCC | 30.36 | 30059200 | |
211 | Phosphorylation | SSSSSSRSQSAAVTP CCCCCCCCCCCCCCC | 30.36 | 29255136 | |
213 | O-linked_Glycosylation | SSSSRSQSAAVTPSS CCCCCCCCCCCCCCC | 21.31 | 30059200 | |
213 | Phosphorylation | SSSSRSQSAAVTPSS CCCCCCCCCCCCCCC | 21.31 | 29255136 | |
217 | Phosphorylation | RSQSAAVTPSSTTSS CCCCCCCCCCCCCCC | 16.84 | 23927012 | |
217 | O-linked_Glycosylation | RSQSAAVTPSSTTSS CCCCCCCCCCCCCCC | 16.84 | 30059200 | |
219 | O-linked_Glycosylation | QSAAVTPSSTTSSTR CCCCCCCCCCCCCCC | 30.83 | 30059200 | |
219 | Phosphorylation | QSAAVTPSSTTSSTR CCCCCCCCCCCCCCC | 30.83 | 23927012 | |
220 | O-linked_Glycosylation | SAAVTPSSTTSSTRA CCCCCCCCCCCCCCC | 36.59 | 30059200 | |
220 | Phosphorylation | SAAVTPSSTTSSTRA CCCCCCCCCCCCCCC | 36.59 | 23927012 | |
221 | Phosphorylation | AAVTPSSTTSSTRAT CCCCCCCCCCCCCCC | 34.73 | 23927012 | |
221 | O-linked_Glycosylation | AAVTPSSTTSSTRAT CCCCCCCCCCCCCCC | 34.73 | 30059200 | |
222 | Phosphorylation | AVTPSSTTSSTRATP CCCCCCCCCCCCCCC | 23.72 | 23927012 | |
222 | O-linked_Glycosylation | AVTPSSTTSSTRATP CCCCCCCCCCCCCCC | 23.72 | 30059200 | |
223 | O-linked_Glycosylation | VTPSSTTSSTRATPA CCCCCCCCCCCCCCC | 29.78 | 30059200 | |
223 | Phosphorylation | VTPSSTTSSTRATPA CCCCCCCCCCCCCCC | 29.78 | 23927012 | |
224 | Phosphorylation | TPSSTTSSTRATPAP CCCCCCCCCCCCCCC | 21.59 | 23927012 | |
224 | O-linked_Glycosylation | TPSSTTSSTRATPAP CCCCCCCCCCCCCCC | 21.59 | 30059200 | |
225 | Phosphorylation | PSSTTSSTRATPAPS CCCCCCCCCCCCCCC | 24.88 | 23927012 | |
225 | O-linked_Glycosylation | PSSTTSSTRATPAPS CCCCCCCCCCCCCCC | 24.88 | 30059200 | |
319 | Phosphorylation | PYLPSGESLPQTADE HCCCCCCCCCCCHHH | 49.20 | 24275569 | |
371 | Ubiquitination | EAVEAANKGDVEAFA HHHHHHHHCCHHHHH | 52.33 | - | |
379 | Ubiquitination | GDVEAFAKAMQNNAK CCHHHHHHHHHHCCC | 37.63 | 21906983 | |
386 | Ubiquitination | KAMQNNAKPEQKEGD HHHHHCCCHHHCCCC | 51.73 | 21906983 | |
390 | Ubiquitination | NNAKPEQKEGDTKDK HCCCHHHCCCCCCCC | 63.10 | 21906983 | |
395 | Ubiquitination | EQKEGDTKDKKDEEE HHCCCCCCCCHHHHH | 72.75 | 21906983 | |
397 | Ubiquitination | KEGDTKDKKDEEEDM CCCCCCCCHHHHHHC | 64.78 | 21906983 | |
398 | Ubiquitination | EGDTKDKKDEEEDMS CCCCCCCHHHHHHCC | 79.21 | 21906983 | |
405 | Phosphorylation | KDEEEDMSLD----- HHHHHHCCCC----- | 41.53 | 30278072 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ADRM1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ADRM1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Mass spectrometric characterization of the affinity-purified human26S proteasome complex."; Wang X., Chen C.-F., Baker P.R., Chen P.-L., Kaiser P., Huang L.; Biochemistry 46:3553-3565(2007). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-213 AND THR-217, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211; THR-217; SER-220AND SER-405, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-405, AND MASSSPECTROMETRY. | |
Ubiquitylation | |
Reference | PubMed |
"Quantitative analysis of global ubiquitination in HeLa cells by massspectrometry."; Meierhofer D., Wang X., Huang L., Kaiser P.; J. Proteome Res. 7:4566-4576(2008). Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-34, AND MASSSPECTROMETRY. |